Susquehanna International Group, LLP Timber Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.1 - $0.3 $32,045 - $96,135	320,452 New	320,452 $38,000
Q2 2022 Aug 15, 2022	SELL	$0.24 - $0.39 $11,845 - $19,249	-49,357 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.28 - $0.41 $13,819 - $20,236	49,357 New	49,357 $19,000
Q4 2021 Feb 14, 2022	SELL	$0.38 - $0.89 $25,548 - $59,836	-67,232 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$0.89 - $1.18 $59,836 - $79,333	67,232 New	67,232 $61,000
Q4 2020 Feb 16, 2021	SELL	$0.72 - $1.52 $10,626 - $22,433	-14,759 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$0.92 - $2.4 $13,578 - $35,421	14,759 New	14,759 $15,000

Ticker TMBR
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,524,992
Description
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.